JETRO AnnouncementsApply Now: Regenerative Medicine/Cell and Gene Therapy Startups for Japan Entry Acceleration Program 2025

Sep 08, 2025

JEAP, short for the Japan Entry Acceleration Program, is built on the idea of turning bold visions into real opportunities. The program represents creativity without limits, fresh beginnings in Japan, and the energy to connect globally and grow faster.

With this spirit at its core, JEAP invites pioneering startups in regenerative medicine/cell and gene therapy to join us in shaping the future of healthcare in Japan.

As part of JEAP, selected startups gain access to Japan’s business ecosystem, from tailored mentorship and market insights to direct connections with leading CDMOs/CROs and Pharmaceutical companies, providing the support needed to accelerate entry, collaboration, and growth in one of the world’s most advanced markets.

Logo of the Japan Entry Acceleration Program (JEAP) with “Powered by Invest Japan J-Bridge” at the bottom.
Outline
Program Name Japan Entry Acceleration Program​ 2025
Program Period September 2025 – March 2026
Application Period September 8 – October 31 2025
Location The program will be held mainly online, with the Demo Day taking place in person in Tokyo.
Eligibilities
  1. 1.

    Field of Focus

    • Regenerative Medicine
    • Cell Therapy
    • Gene Therapy (in-vivo, ex-vivo)
    • Tissue Engineering (including Scaffolds)
    • ATMPs (Advanced Therapy Medicinal Products)
    • Cell & Gene Therapy Products
  2. 2.

    Development Stage

    Companies with identified clinical development candidates

  3. 3.

    Interest in Entering the Japanese Market

    Companies that are considering business expansion into Japan or have a concrete interest in the Japanese market.

  4. 4.

    Commitment to Participate in the Program

    Companies must be able to commit to participating in multiple sessions of the program.

  5. 5.

    Demo Day Participation

    Companies must be able to present at Demo Day in Japan and cooperate in related PR activities.

Capacity Approximately 5 startups
Selection Schedule
  1. 1.

    September 8 – October 31, 2025: Application Period

  2. 2.

    Early November 2025: Document Screening

  3. 3.

    Mid to Late November 2025: Interviews

  4. 4.

    Late November 2025: Final Selection

Program Content December 2025:
  • Workshops (online): Practical sessions to deepen understanding of the Japanese market and prepare for collaboration opportunities.
January to February :
  • Mentoring (online): Tailored guidance from experts and professionals to refine business strategy, regulatory awareness, and partnership approaches.
  • Matching (online): Curated introductions and meetings with Japanese CDMOs/CROs and pharmaceutical companies relevant to your technology and business needs.
End of February:
  • Demo Day (onsite, Tokyo): Final presentation in Japan to showcase your solutions to an audience of Japanese companies, investors, and ecosystem partners.
Participation fee

Free of charge.

Note: Travel and accommodation expenses will be reimbursed according to JETRO’s internal regulations and budget limits. Expenses beyond the approved scope are not covered.
In the event of cancellation due to natural disasters, accidents, war, government restrictions, labor disputes, epidemics, or other force majeure events, JETRO will bear the relevant costs.

Organizer JETRO

How to Apply

Please provide the required information in the application form below.

Application Deadline

Friday, October 31. 2025 23:59

Contact us

JETRO Investment and Alliance Division, Innovation Department（Point of contact: Saito, Ito, Ono）
E-mail: ive@jetro.go.jp Tel: 03-3582-8347

Contact Us

Investing in and collaborating with Japan

We will do our very best to support your business expansion into and within Japan as well as business collaboration with Japanese companies. Please feel free to contact us via the form below for any inquiries.

Inquiry Form

JETRO Worldwide

Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.

Worldwide Offices